Treatment of refractory hyperparathyroidism in patients on hemodialysis by intermittent oral administration of 1,25(OH)2 vitamin D3

Nephron

Volumn 58, Issue 3, 1991, Pages 288-294

  Muramoto, H ^a   Haruki, K ^a   Yoshimura, A ^a   Nimo, N ^a   Oda, K ^a   Tofuku, Y ^a  

^a Naruwa General Hospital   (Japan)

Author keywords

1,25(OH)2 vitamin D3; hemodialysis; secondary hyperparathyroidism

Indexed keywords

ALFACALCIDOL; CALCITRIOL;

ADULT; ARTICLE; CLINICAL ARTICLE; FEMALE; HEMODIALYSIS; HUMAN; MALE; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; SECONDARY HYPERPARATHYROIDISM;

ADMINISTRATION, ORAL; ADULT; CALCITRIOL; CALCIUM; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; HUMAN; HYPERCALCEMIA; HYPERPARATHYROIDISM; MALE; MIDDLE AGE; PARATHYROID HORMONES; RENAL DIALYSIS;

EID: 0025892350     PISSN: 00282766     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (0)